1. LS has a slightly decreased risk of liver cancer.
2. Start LS on a SGLT-2 since it will prevent further liver damage.
3. Refer LS to a diabetes specialist to assist with lifestyle changes.
4. Avoid starting a GLP-1 Receptor Agonists until ALT and AST are negative.

Click here to test your knowledge!

---

Want more practice?
Join us live on September 9th at 11:30 AM (PST) for our
Cancer & Diabetes Webinar | Level 4 – Advanced Level | 1.5 CEs

Patients with cancer often experience hyperglycemia secondary to treatment, which can increase risk of infection and compromise their nutritional status. In addition, recent research has identified the link between diabetes and cancer. Join us to learn more about this unexpected link and treatment strategies for steroid-induced hyperglycemia using a case study approach. 

Topics Include:

• Discuss the relationship between cancer, hyperglycemia and insulin resistance.
• State 3 benefits of normalizing glucose levels during chemotherapy.
• Using a case study approach, discuss strategies to improve glucose levels and quality of life.

---

Sign up for Diabetes Blog Bytes – we post one daily Blog Byte from Monday to Friday. And of course, Tuesday is our Question of the Week. It’s Informative and FREE!  Sign up below!

[yikes-mailchimp form=”1″]

---

Accreditation: Diabetes Education Services is an approved provider by the California Board of Registered Nursing, Provider 12640, and Commission on Dietetic Registration (CDR), Provider DI002. Since these programs are approved by the CDR it satisfies the CE requirements for the CDCES regardless of your profession.*  

The use of DES products does not guarantee the successful passage of the CDCES exam. CBDCE does not endorse any preparatory or review materials for the CDCES exam, except for those published by CBDCE.

[yikes-mailchimp form=”1″]